Should Pacer US Cash Cows 100 ETF (COWZ) Be on Your Investing Radar?
https://www.zacks.com/stock/news/2227682/should-pacer-us-cash-cows-100-etf-cowz-be-on-your-investing-radar?cid=CS-ZC-FT-style_box_etf-2227682
Feb 19, 2024 - Style Box ETF report for COWZ
0
CVS and Walgreens to start selling abortion pill mifepristone this month
https://www.cnbc.com/2024/03/01/cvs-walgreens-to-start-selling-abortion-pill-mifepristone-this-month-.html
Mar 01, 2024 - CVS and Walgreens have received certification from the FDA to dispense the commonly used mifepristone at their retail pharmacies, spokespeople told CNBC.
0
CVS Health (CVS) Expands In-Home Diagnostic Care With New Test
https://www.zacks.com/stock/news/2236218/cvs-health-cvs-expands-in-home-diagnostic-care-with-new-test?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2236218
Mar 05, 2024 - CVS Health's (CVS) new launch will enable early detection of heart arrhythmia and can help mitigate symptoms and more severe complications.
0
CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors
https://www.zacks.com/stock/news/2237629/cvs-health-cvs-stock-declines-while-market-improves-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2237629
Mar 07, 2024 - CVS Health (CVS) reachead $74.30 at the closing of the latest trading day, reflecting a -0.05% change compared to its last close.
0
CVS Health (CVS) Down 1% Since Last Earnings Report: Can It Rebound?
https://www.zacks.com/stock/news/2238122/cvs-health-cvs-down-1-since-last-earnings-report-can-it-rebound?cid=CS-ZC-FT-realtime_blog-2238122
Mar 08, 2024 - CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
CVS Health: Better Times Likely Ahead
https://seekingalpha.com/article/4677494-cvs-health-better-times-likely-ahead?source=feed_all_articles
Mar 11, 2024 - CVS Health is dealing with higher medical care costs, implementation struggles, and leadership changes. Learn why CVS stock is a Buy.
0
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
https://www.cnbc.com/2024/03/16/wegovy-heart-health-insurance-coverage.html
Mar 16, 2024 - Some health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say could significantly strain their budgets.
0
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
https://www.cnbc.com/2024/03/18/wegovy-heart-health-insurance-coverage.html
Mar 18, 2024 - Some health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say could significantly strain their budgets.
0
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
https://www.zacks.com/stock/news/2248988/cvs-health-corporation-cvs-is-attracting-investor-attention-here-is-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|most_searched_stocks-2248988
Apr 02, 2024 - CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
0
CVS Health (CVS) Outperforms Broader Market: What You Need to Know
https://www.zacks.com/stock/news/2250087/cvs-health-cvs-outperforms-broader-market-what-you-need-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2250087
Apr 03, 2024 - CVS Health (CVS) closed the most recent trading day at $74.60, moving +1.06% from the previous trading session.
0
Page 1>